Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, announced that the company will be participating in the LD Micro Invitational XI Conference, being held virtually from June 8-10, 2021.
June 2, 2021
· 2 min read